Back to search results

HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer · Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Anhui Provincial Cancer Hospital, Hefei, Anfei, China

  • Lingying Wu, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Lingying Wu, MD) · wulingying@csco.org.cn · 010-87788996
    Contact: Study coordinator (Dawei Wu) · cancergcp@163.com · 010-87788495

  • Peking University Cancer Hospital, Beijing, Beijing Municipality, China

  • Chongqing University cancer Hospital, Chongqing, Chongqing Municipality, China

  • Fujian Cancer Hospital, Fuzhou, Fujian, China

  • Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou, Guangdong, China

  • Guangxi Cancer Hospital, Nanning, Guangxi, China

  • Hainan General Hospital, Haikou, Hainan, China

  • The fourth Hospital of Heibei Medical University, Shijiazhuang, Hebei, China

  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

  • Henan Cancer Hospital, Zhengzhou, Henan, China

  • Hubei Cancer University, Wuhan, Hubei, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China

  • Hunan Cancer Hosipital, Changsha, Hunan, China

  • Xiangya Hospital of Central South University, Changsha, Hunan, China

  • Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China

  • Jilin Cancer Hospital, Changchun, Jilin, China

  • The Second Hospital of Dalian Medical University, Dalian, Liaoning, China

  • Liaoning Cancer Hospital, Shenyang, Liaoning, China

  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

  • Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China

  • Obstetrics & Gynecology Hospital of Fudan University, Shanghai, Shanghai Municipality, China

  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

  • The first Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China

  • Tianjin Medical University cancer institute & Hospital, Tianjin, Tianjin Municipality, China

  • Affiliated Cancer Hospital of Xinjiang Medical University, Xinjiang, Xinjiang, China

  • Yunnan Cancer Hospital, Kunming, Yunnan, China

  • Zhejiang Cancer Hospital, Hanzhou, Zhejiang, China

Study leads

  • Lingying Wu, MD

    Principal Investigator

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View source on ClinicalTrials.gov(opens in a new tab)